In a very simplified view of many AD research data taken together, the small GTPase Rab5 can be depicted as a convergence point (Figure 1) for multiple established pathogenic drivers of neurodegeneration in AD (e.g., downstream of APP, APP-β-CTF, β-CTF, Aβ, ApoE4, and others). This evidence concerns the gene APP and Alzheimer disease.